IL-2 production by dendritic cells is not critical for the activation of cognate and innate effectors in draining lymph nodes

European Journal of Immunology

Volumn 35, Issue 10, 2005, Pages 2840-2850

  Schartz, Noël E C ^a,b   Chaput, Nathalie ^a   Taieb, Julien ^a,d   Bonnaventure, Pierre ^a   Trébeden Nègre, Hélène ^c   Terme, Magali ^a   Ménard, Cédric ^a   Lebbé, Céleste ^b   Schimpl, Anneliese ^e   Ardouin, Patrice ^a   Zitvogel, Laurence ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b Service de Dermatologie 2   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d Service d'Hépato Gastroentérologie   (France)

^e UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Cytotoxic T lymphocytes; Dendritic cells; IL 2; NK cells

Indexed keywords

INTERLEUKIN 2; LIPOPOLYSACCHARIDE; OVALBUMIN; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9;

ADOPTIVE TRANSFER; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; DENDRITIC CELL; EX VIVO STUDY; FEMALE; INFECTION RESISTANCE; INNATE IMMUNITY; LYMPHATIC DRAINAGE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; T LYMPHOCYTE ACTIVATION; VIRUS IMMUNITY;

ADOPTIVE TRANSFER; ANIMALS; BONE MARROW; BONE MARROW CELLS; DENDRITIC CELLS; FEMALE; INTERLEUKIN-2; KILLER CELLS, NATURAL; LIPOPOLYSACCHARIDES; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; T-LYMPHOCYTES, CYTOTOXIC;

EID: 27644433917     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200425628     Document Type: Article

References (35)

1. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B. and Palucka, K., Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000. 18: 767-811.
2. Andrews, D. M., Andoniou, C. E., Granucei, F., Ricciardi-Castagnoli, P. and Degli-Esposti, M. A., Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nat. Immunol. 2001. 2: 1077-1084.
3. Huang, Q., Liu, D., Majewski, P., Schulte, L. C., Korn, J. M., Young, R. A., Lander, E. S. and Hacohen, N., The plasticity of dendritic cell responses to pathogens and their components. Science 2001. 294: 870-875.
4. Cella, M., Engering, A., Pinet, V., Pieters, J. and Lanzavecchia, A., Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 1997. 388: 782-787.
5. Langenkamp, A., Messi, M., Lanzavecchia, A. and Sallusto, F., Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat. Immunol. 2000. 1: 311-316.
6. Granucci, F., Feau, S., Angeli, V., Trottein, F. and Ricciardi-Castagnoli, P., Early IL-2 production by mouse dendritic cells is the result of microbial-induced priming. J. Immunol. 2003. 170: 5075-5081.
7. Geginat, J., Sallusto, F. and Lanzavecchia, A., Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells. J. Exp. Med. 2001. 194: 1711-1719.
8. Terme, M., Tomasello, E., Maruyama, K., Crepineau, F., Chaput, N., Flament, C., Marolleau, J. P. et al., IL-4 confers NK stimulatory capacity to murine dendritic cells: a signaling pathway involving KARAP/DAP12-triggering receptor expressed on myeloid cell 2 molecules. J. Immunol. 2004. 172: 5957-5966.
9. Fernandez, N. C., Lozier, A., Flament, C., Ricciardi-Castagnoli, P., Bellet, D., Suter, M., Perricaudet, M. et al., Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat. Med. 1999. 5: 405-411.
10. Fujii, S., Shimizu, K., Smith, C., Bonifaz, L. and Steinman, R. M., Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J. Exp. Med. 2003. 198: 267-279.
11. Granucci, F., Vizzardelli, C., Pavelka, N., Feau, S., Persico, M., Virzi, E., Rescigno, M. et al., Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat. Immunol. 2001. 2: 882-888.
12. + T cell survival but not for antigen proliferation. Nat. Immunol. 2000. 1: 54-58.
13. Liu, B., Podack, E. R., Allison, J. P. and Malek, T. R., Generation of primary tumor-specific CTL in vitro to immunogenic and poorly immunogenic mouse tumors. J. Immunol. 1996. 156: 1117-1125.
14. Mehrotra, P. T., Grant, A. J. and Siegel, J. P., Synergistic effects of IL-7 and IL-12 on human T cell activation. J. Immunol. 1995. 154: 5093-5102.
15. Malek, T. R., Yu, A., Scibelli, P., Lichtenheld, M. G. and Codias, E. K., Broad programming by IL-2 receptor signaling for extended growth to multiple cytokines and functional maturation of antigen-activated T cells. J. Immunol. 2001. 166: 1675-1683.
16. Bathe, O. F., Dalyot-Herman, N. and Malek, T. R., IL-2 during in vitro priming promotes subsequent engraftment and successful adoptive tumor immunotherapy by persistent memory phenotypic CD8(+) T cells. J. Immunol. 2001. 167: 4511-4517.
17. + T cells. J. Exp. Med. 1997. 186: 1407-1418.
18. Sauma, D., Michea, P., Lennon-Dumenil, A. M., Fierro, A., Morales, J., Rosemblatt, M. and Bono, M. R., Interleukin-4 selectively inhibits interleukin-2 secretion by lipopolysaccharide-activated dendritic cells. Scand. J. Immunol. 2004. 59: 183-189.
19. Villacres, M. C. and Bergmann, C. C., Enhanced cytotoxic T cell activity in IL-4-deficient mice. J. Immunol. 1999. 162: 2663-2670.
20. Aung, S., Tang, Y. W. and Graham, B. S., Interleukin-4 diminishes CD8(+) respiratory syncytial virus-specific cytotoxic T-lymphocyte activity in vivo. J. Virol. 1999. 73: 8944-8949.
21. Ehrhardt, R. O., Ludviksson, B. R., Gray, B., Neurath, M. and Strober, W., Induction and prevention of colonic inflammation in IL-2-deficient mice. J. Immunol. 1997. 158: 566-573.
22. Wolf, M., Schimpl, A. and Hunig, T., Control of T cell hyperactivation in IL-2-deficient mice by CD4(+)CD2S(-) and CD4(+)CD25(+) Tcells: evidence for two distinct regulatory mechanisms. Eur. J. Immunol. 2001. 31: 1637-1645.
23. Andrews, D. M., Scalzo, A. A., Yokoyama, W. M., Smyth, M. J. and Degli-Esposti, M. A., Functional interactions between dendritic cells and NK cells during viral infection. Nat. Immunol. 2003. 4: 175-181.
24. Borg, C., Jalil, A., Laderach, D., Maruyama, K., Wakasugi, H., Charrier, S., Ryffel, B. et al., NK cell activation by dendritic cells (DCs) requires the formation ofa synapse leading to IL-12 polarization in DCs. Blood 2004. 104: 3267-3275.
25. Koka, R., Burkett, P., Chien, M., Chai, S., Boone, D. L. and Ma, A., Cutting edge: routine dendritic cells require IL-15R alpha to prime NK cells. J. Immunol. 2004. 173: 3594-3598.
26. Granucci, F., Zanoni, I., Pavelka, N., Van Dommelen, S. L., Andoniou, C. E., Belardelli, F., Degli Esposti, M. A. and Ricciardi-Castagnoli, P., A contribution of mouse dendritic cell-derived IL-2 for NK cell activation. J. Exp. Med. 2004. 200: 287-295.
27. Gerosa, F., Gobbi, A., Zorzi, P., Burg, S., Briere, F., Carta, G. and Trinchieri, G., The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J. Immunol. 2005. 174: 727-734.
28. Fehniger, T. A., Cooper, M. A., Nuovo, G. J., Cella, M., Facchetti, F., Colonna, M. and Caligiuri, M. A., CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 2003. 101: 3052-3057.
29. van den Broeke, L. T., Daschbach, E., Thomas, E. K., Andringa, G. and Berzofsky, J. A., Dendritic cell-induced activation of adaptive and innate antitumor immunity. J. Immunol. 2003. 171: 5842-5852.
30. + dendritic cells (DC) veto cells? The role of CD8 on DC in DC development and in the regulation of CD4 and CD8 T cell responses. Int. Immunol. 1997. 9: 1061-1064.
31. Feau, S., Facchinetti, V., Granucci, F., Citterio, S., Jarrossay, D., Seresini, S., Protti, M. P. et al., Dendritic cell-derived IL-2 production is regulated by IL-15 in humans and in mice. Blood 2005. 105: 697-702.
32. Schorle, H., Holtschke, T., Hunig, T., Schimpl, A. and Horak, I., Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 1991. 352: 621-624.
33. Okabe, M., Ikawa, M., Kominami, K., Nakanishi, T. and Nishimune, Y., 'Green mice' as a source of ubiquitous green cells. FEBS Lett. 1997. 407: 313-319.
34. Chaput, N., Schartz, N. E., Andre, F., Taieb, J., Novault, S., Bonnaventure, P., Aubert, N. et al., Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection. J. Immunol. 2004. 172: 2137-2146.
35. Mayordomo, J. I., Loftus, D. J., Sakamoto, H., De Cesare, C. M., Appasamy, P. M., Lotze, M. T., Storkus, W. J. et al., Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines. J. Exp. Med. 1996. 183: 1357-1365.